Literature DB >> 2124207

Antigen-presenting cells for CD8+ T cells.

J Sprent1, M Schaefer.   

Abstract

Evidence is presented that a wide variety of cell types are capable of presenting class I alloantigens to purified unprimed CD8+ cells in the absence of added help. These cells include dendritic cells, a population of Ia- Thy 1- cells in spleen, peritoneal exudate cells and one of three T-tumor lines. Some cell types, e.g. T-blast cells and overnight-adherent peritoneal exudate cells (OA-PEC) only expressed antigen-presenting cell (APC) function in the presence of added lymphokines. Stimulation of OA-PEC with small concentrations of lipopolysaccharide or treatment of T-blast cells with neuraminidase (N'dase) strongly enhanced the APC function of these cells and led to helper-independent responses. N'dase treatment of small resting T stimulators caused partial restoration of APC function: strong responses were observed but only in the presence of exogenous lymphokines. Studies with T-tumor lines preincubated with IFN-gamma suggested that APC function correlates closely with antigen (class I) expression. Collectively, the data support the view that APC function depends upon a multiplicity of factors including antigen density, the level of accessory (adhesion) molecules and net surface charge. It is suggested that the potency of APC function is largely a reflection of the overall avidity of T-APC interaction: high-avidity binding leads to helper-independent responses whereas weaker binding results in helper-dependent responses.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2124207     DOI: 10.1111/j.1600-065x.1990.tb00574.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  11 in total

1.  Ontogeny of T cell tolerance to peripherally expressed antigens.

Authors:  D J Morgan; C Kurts; H T Kreuwel; K L Holst; W R Heath; L A Sherman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  Human dendritic cells handling of binding, uptake and degradation of free and IgG-immune complexed dinitrophenylated human serum albumin in vitro.

Authors:  M Larsson; J Berge; A G Johansson; U Forsum
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

Review 3.  The synovio-entheseal complex in enthesoarthritis.

Authors:  Angelo De Cata; Michele Inglese; Rosa Rubino; Francesca Molinaro; Gianluigi Mazzoccoli
Journal:  Clin Exp Med       Date:  2015-02-12       Impact factor: 3.984

4.  An autologous oral DNA vaccine protects against murine melanoma.

Authors:  R Xiang; H N Lode; T H Chao; J M Ruehlmann; C S Dolman; F Rodriguez; J L Whitton; W W Overwijk; N P Restifo; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

5.  Human hepatoma cells expressing MHC antigens display accessory cell function: dependence on LFA-1/ICAM-1 interaction.

Authors:  M Paroli; G Carloni; A Franco; G De Petrillo; E Alfani; A Perrone; V Barnaba
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

6.  Antigen-presenting characteristics of peritoneal cells of Salmonella enteritidis 11RX-infected mice.

Authors:  M Pope; I Kotlarski
Journal:  Immunology       Date:  1992-10       Impact factor: 7.397

7.  Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine.

Authors:  V Bronte; M W Carroll; T J Goletz; M Wang; W W Overwijk; F Marincola; S A Rosenberg; B Moss; N P Restifo
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

8.  Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes.

Authors:  M Theobald; J Biggs; J Hernández; J Lustgarten; C Labadie; L A Sherman
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

9.  Response of naive antigen-specific CD4+ T cells in vitro: characteristics and antigen-presenting cell requirements.

Authors:  M Croft; D D Duncan; S L Swain
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

10.  Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN.

Authors:  Cory L Ahonen; Christie L Doxsee; Sean M McGurran; Tony R Riter; William F Wade; Richard J Barth; John P Vasilakos; Randolph J Noelle; Ross M Kedl
Journal:  J Exp Med       Date:  2004-03-08       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.